Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/ACTIVE-BIOTECH-AB-6491412/attualita/Active-Biotech-annuncia-il-primo-paziente-dosato-nella-parte-di-combinazione-dello-studio-di-fase-Ib-37816759/?utm_source=whatsapp&utm_medium=social&utm_campaign=share